Literature DB >> 998543

Pantothenic acid, coenzyme A, and human chronic ulcerative and granulomatous colitis.

J J Ellestad-Sayed, R A Nelson, M A Adson, W M Palmer, E H Soule.   

Abstract

To investigate further an apparent relationship between chronic ulcerative and granulomatous colitis and pantothenic acid deficiency, colonic tissues obtained at the time of colectomy in 29 patients with these disorders were assayed for pantothenic acid and for coenzyme A (CoA) activity. For comparison, normal colonic tissues free of pathological lesions were obtained from 31 patients having colectomy for carcinoma or diverticulitis. Plasma, red blood cells, and colonic mucosa were assayed microbiologically for free and total pantothenic acid. The activity of CoA in colonic mucosa was determined by assaying the acetylation of sulfanilamide. Concentrations of free, bound, and total pantothenic acid in blood and in colonic mucosa did not differ between the two groups of patients. Bound pantothenic acid increased linearly with total pantothenic acid. Colonic mucosa concentrated free pantothenic acid to about 50 times the level of blood, and pantothenic acid in red cells was similar to the concentration in plasma. Compared to normal gut mucosa, CoA activity was markedly low in mucosa from patients with chronic ulcerative or granulomatous disease despite the presence of normal amounts of free and bound pantothenic acid. A block in the conversion of bound pantothenic acid to CoA in diseased mucosa is suggested.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 998543     DOI: 10.1093/ajcn/29.12.1333

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  12 in total

1.  Nitric oxide effect on colonocyte metabolism: co-action of sulfides and peroxide.

Authors:  W E Roediger; W J Babidge
Journal:  Mol Cell Biochem       Date:  2000-03       Impact factor: 3.396

Review 2.  Metabolism of large bowel mucosa in health and disease.

Authors:  G Latella; R Caprilli
Journal:  Int J Colorectal Dis       Date:  1991-05       Impact factor: 2.571

3.  Pantothenic acid biosynthesis in the parasite Toxoplasma gondii: a target for chemotherapy.

Authors:  Sarmad N Mageed; Fraser Cunningham; Alvin Wei Hung; Hernani Leonardo Silvestre; Shijun Wen; Tom L Blundell; Chris Abell; Glenn A McConkey
Journal:  Antimicrob Agents Chemother       Date:  2014-07-21       Impact factor: 5.191

4.  Combined oral sodium butyrate and mesalazine treatment compared to oral mesalazine alone in ulcerative colitis: randomized, double-blind, placebo-controlled pilot study.

Authors:  P Vernia; G Monteleone; G Grandinetti; G Villotti; E Di Giulio; G Frieri; A Marcheggiano; F Pallone; R Caprilli; A Torsoli
Journal:  Dig Dis Sci       Date:  2000-05       Impact factor: 3.199

5.  Selective reduction of fatty acid oxidation in colonocytes: correlation with ulcerative colitis.

Authors:  W E Roediger; S Nance
Journal:  Lipids       Date:  1990-10       Impact factor: 1.880

Review 6.  Gastrointestinal and Hepatic Complications of Immune Checkpoint Inhibitors.

Authors:  Peyton Cramer; Robert S Bresalier
Journal:  Curr Gastroenterol Rep       Date:  2017-01

7.  Changes of plasma fasting carnitine ester profile in patients with ulcerative colitis.

Authors:  Judit Bene; Katalin Komlósi; Viktória Havasi; Gábor Talián; Beáta Gasztonyi; Krisztina Horváth; Gyula Mózsik; Béla Hunyady; Béla Melegh; Mária Figler
Journal:  World J Gastroenterol       Date:  2006-01-07       Impact factor: 5.742

Review 8.  Insights gained from P. falciparum cultivation in modified media.

Authors:  Sanjay A Desai
Journal:  ScientificWorldJournal       Date:  2013-07-09

9.  Severe pantothenic acid deficiency induces alterations in the intestinal mucosal proteome of starter Pekin ducks.

Authors:  Jing Tang; Yulong Feng; Bo Zhang; Yongbao Wu; Zhanbao Guo; Suyun Liang; Zhengkui Zhou; Ming Xie; Shuisheng Hou
Journal:  BMC Genomics       Date:  2021-06-30       Impact factor: 3.969

10.  Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis.

Authors:  Krista Dubin; Margaret K Callahan; Boyu Ren; Raya Khanin; Agnes Viale; Lilan Ling; Daniel No; Asia Gobourne; Eric Littmann; Curtis Huttenhower; Eric G Pamer; Jedd D Wolchok
Journal:  Nat Commun       Date:  2016-02-02       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.